Navigating the complexities of single-cell sequencing shouldn't hinder your research goals. At Almaden Genomics, we specialize in simplifying the #omics analysis process with g.nome®, our end-to-end analysis platform. By offering step-by-step guided workflows and comprehensive services—from data sourcing to pipeline development and tertiary analysis—we are committed to efficiency and clarity, empowering researchers to focus on insights rather than intricacies. Interested in optimizing your genomic research? Watch the full webinar to see how we simplify #scRNAseq: https://lnkd.in/d55hvkww
About us
Almaden Genomics is accelerating genomic discovery with g.nome, a cloud-native platform designed to streamline genomic workflows. Brought to market by a team of bioinformaticians, engineers and industry professionals, Almaden’s g.nome platform allows for a low-code/no-code pipeline build. With a visual drag-and-drop pipeline builder that utilizes toolkits and pre-built workflows from a curated library, g.nome is giving power to researchers — enabling them to import custom code, handle big datasets reliably and optimize team collaboration from anywhere. With g.nome, research teams can do what they do best: focus on the science.
- Website
-
https://almaden.io
External link for Almaden Genomics
- Industry
- Biotechnology Research
- Company size
- 11-50 employees
- Headquarters
- Dallas, Texas
- Type
- Privately Held
Locations
-
Primary
1409 Botham Jean Blvd
Suite 1007
Dallas, Texas 75215, US
Employees at Almaden Genomics
-
Michele Hodde
Chief Operating Officer | Growth Creator | Business Strategist | Brand Cultivator | Tech Enthusiast
-
Joe D'Cruz
Managing Director Catalyze Partners, Board of Directors at C4ADS
-
Kit Fuhrman
Head of Product
-
Graham Hughes, MD
Physician leader with a proven track record of strategic and operational leadership in the areas of digital health / healthcare IT.
Updates
-
Come join us next week at the BVS Biotech Community Event in San Diego's SOVA District! We'll be there to talk about our end-to-end #omics analysis solution, g.nome®. No matter your skill level, come meet with us to learn how g.nome can speed up your analysis. We hear there will be tacos and beer at the event, as well as a raffle 👀 Hope to see you there!
Come join me August 27 for the BVS Biotech Community Event at the SOVA Science District in San Diego! Stop by our table to talk #datanalysis, or message me if there is a better time to meet up. You can register for the event here: bit.ly/4clgtH4 Hope to see you there!
-
-
In colorectal cancer (CRC), where genetic factors play a pivotal role in understanding pathophysiology, identifying differentially expressed genes is essential for advancing diagnosis, prognosis, and treatment strategies. Re-analyzing public RNA-seq data is crucial for validating findings and uncovering new insights, but managing and analyzing such data can be challenging. The Almaden Genomics g.nome® platform simplifies this process, offering end-to-end functionality that covers everything from data acquisition, to visualization, to tertiary analysis, enabling researchers to quickly uncover gene expression patterns. To demonstrate this, we conducted a differential gene expression analysis on RNA-seq data from CRC patients, re-analyzing four transcriptomics datasets from the Sequence Read Archive (SRA) referenced in a study by Hosseini & Nemati. Continue reading: https://lnkd.in/gt6g9EFN #rnaseq #bioinformatics #cancergenomics
-
The Almaden team will be at this month's BVS Biotech Community Event in San Diego to talk #omics data analysis. Will you be there? Let us know if the comments!
Come join me August 27 for the BVS Biotech Community Event at the SOVA Science District in San Diego! Stop by our table to talk #datanalysis, or message me if there is a better time to meet up. You can register for the event here: bit.ly/4clgtH4 Hope to see you there!
-
-
In our latest webinar, our experts demonstrated how g.nome® can simplify bulk RNA sequencing analysis. Designed for biologists who may not have coding experience, g.nome's questionnaire-style Guided Workflows makes it easy to explore data. In this clip, Chief Scientific Officer Mark Kunitomi demonstrates how easy it is to generate detailed reports with our guided workflows, utilizing both local data and data from public repositories. Using our intuitive interface, you can simply set a few key parameters, hit 'run', and focus on exploring results through auto-generated reports with key visualizations. Watch the full webinar here: https://lnkd.in/gbmEiqqs #rnaseq #colorectalcancer #datavisualization
-
Walden Biosciences, a leading biotechnology company focused on kidney disease #therapeutics, faced significant challenges in their transcriptomic research due to software limitations. These limitations included lack of customization, reliance on coding expertise, and extended analysis times, all of which hindered their team's ability to generate actionable insights and advance their mission. In need of a more efficient solution, the Walden team adopted g.nome®, which addressed these challenges by providing a no-code, customizable, cloud-native solution. The g.nome platform transformed their research workflow and enabled Walden's Transcriptomic Scientist to conduct tailored analyses without extensive coding, significantly reducing analysis time and enhancing insights. This integration streamlined data processing and enabled the creation of compelling visualizations, facilitating effective communication of research findings. Read the full case study: https://lnkd.in/eaEuDk9P #personalizedmedicine #transcriptomics
Walden Biosciences: Streamlining Transcriptomic Analysis for Kidney Therapies
almaden.io
-
LAST CHANCE TO REGISTER ⏰ Join our experts tomorrow as they demonstrate how to easily identify biomarkers using g.nome’s Guided Workflows. Don't miss out—register now: https://lnkd.in/gshV9yAT
Interested in exploring biomarkers but unsure how to analyze RNA-sequencing data? Join us on August 6 as Almaden Genomics' Mark Kunitomi, Chief Scientific Officer, and Hannah Schuyler, Director of Business Development, showcase how biologists can leverage g.nome’s Guided Workflows to perform differential expression analyses from FASTQ files. You will learn how to uncover significant insights and drive your research forward. JOIN OUR WEBINAR TO LEARN HOW TO: 🧬️ Simplify RNASeq analysis: Generate visualizations from publicly fetched data with minimal effort. 🧬️ Confidently assess quality: Perform rigorous QC via simple visual reports. 🧬️ Identify biomarkers: Highlight strong candidates through differential expression analysis and gene set enrichment. Discover how to quickly and easily identify biomarkers using g.nome’s intuitive platform, even without extensive bioinformatics expertise. Register now: https://lnkd.in/gshV9yAT
This content isn’t available here
Access this content and more in the LinkedIn app
-
NEXT WEEK 📅 If you're interested in exploring #biomarkers and advancing your research, join us for our webinar on how biologists can leverage g.nome’s Guided Workflows for RNA-sequencing data analysis. We'll demonstrate how to perform differential expression analyses from FASTQ files, generate visualizations with minimal effort, confidently assess quality, and identify biomarkers through gene set enrichment. Register now: https://lnkd.in/gshV9yAT
Interested in exploring biomarkers but unsure how to analyze RNA-sequencing data? Join us on August 6 as Almaden Genomics' Mark Kunitomi, Chief Scientific Officer, and Hannah Schuyler, Director of Business Development, showcase how biologists can leverage g.nome’s Guided Workflows to perform differential expression analyses from FASTQ files. You will learn how to uncover significant insights and drive your research forward. JOIN OUR WEBINAR TO LEARN HOW TO: 🧬️ Simplify RNASeq analysis: Generate visualizations from publicly fetched data with minimal effort. 🧬️ Confidently assess quality: Perform rigorous QC via simple visual reports. 🧬️ Identify biomarkers: Highlight strong candidates through differential expression analysis and gene set enrichment. Discover how to quickly and easily identify biomarkers using g.nome’s intuitive platform, even without extensive bioinformatics expertise. Register now: https://lnkd.in/gshV9yAT
This content isn’t available here
Access this content and more in the LinkedIn app
-
Discover how Almaden Genomics can transform your research journey from data to insights on g.nome®, our end-to-end #omics data analysis platform. From data engineering and harmonization to building customized workflows and expert scientific consulting, we provide the tools and expertise to accelerate your discoveries. Explore how Almaden Genomics can empower your research: https://lnkd.in/gZk2YQNE
-
-
Survival analysis is crucial in cancer research, offering unique insights into treatment efficacy. Our recent use case demonstrates the g.nome® platform's capability to utilize public datasets to simplify survival analysis and reveal key genetic markers that influence patient outcomes. By utilizing g.nome's user-friendly, no-code interface, we achieved significant reductions in runtime and costs while conducting in-depth survival studies. Discover how g.nome can help enhance our understanding of colorectal cancer and advance personalized medicine: https://lnkd.in/gkUWdsgP #colorectalcancer #survivalanalysis #personalizedmedicine
USE CASE: Survival Analysis of Colorectal Cancer Patients
almaden.io